TSX:CRON - Toronto Stock Exchange - CA22717L1013 - Common Stock - Currency: CAD
TSX:CRON (2/21/2025, 7:00:00 PM)
2.78
+0.05 (+1.83%)
The current stock price of CRON.CA is 2.78 CAD. In the past month the price increased by 1.09%. In the past year, price decreased by -8.25%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BHC.CA | BAUSCH HEALTH COS INC | 1.91 | 3.76B | ||
TLRY.CA | TILRAY BRANDS INC | N/A | 1.27B | ||
DHT-UN.CA | DRI HEALTHCARE TRUST | 4.95 | 677.85M | ||
GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 560.43M | ||
DHT-U.CA | DRI HEALTHCARE TRUST | 3.5 | 478.55M | ||
ACB.CA | AURORA CANNABIS INC | N/A | 457.53M | ||
WEED.CA | CANOPY GROWTH CORP | N/A | 400.51M | ||
CPH.CA | CIPHER PHARMACEUTICALS INC | 14.04 | 319.88M | ||
HITI.CA | HIGH TIDE INC | N/A | 299.33M | ||
TSND.CA | TERRASCEND CORP | N/A | 271.02M | ||
OGI.CA | ORGANIGRAM HOLDINGS INC | N/A | 229.72M | ||
NGEN.CA | NERVGEN PHARMA CORP | N/A | 203.27M |
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Spinach brand offers pre-rolls infused with cold-filtered cannabis extract and coated in kief, and all-in-one disposable vapes. The Lord Jones is a hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions are a line-up of premium ice water hash infused pre-rolls. This brand also offers vapes and edibles. Its PEACE NATURALS offer Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.
CRONOS GROUP INC
4491 Concession Rd 12
TORONTO ONTARIO M5V2G9 CA
CEO: Kurt T. Schmidt
Employees: 626
Company Website: https://thecronosgroup.com/
Investor Relations: https://ir.thecronosgroup.com/
Phone: 14165040004
The current stock price of CRON.CA is 2.78 CAD. The price increased by 1.83% in the last trading session.
The exchange symbol of CRONOS GROUP INC is CRON and it is listed on the Toronto Stock Exchange exchange.
CRON.CA stock is listed on the Toronto Stock Exchange exchange.
11 analysts have analysed CRON.CA and the average price target is 3.64 CAD. This implies a price increase of 30.84% is expected in the next year compared to the current price of 2.78. Check the CRONOS GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CRONOS GROUP INC (CRON.CA) has a market capitalization of 1.06B CAD. This makes CRON.CA a Small Cap stock.
CRONOS GROUP INC (CRON.CA) currently has 626 employees.
CRONOS GROUP INC (CRON.CA) has a support level at 2.78 and a resistance level at 2.79. Check the full technical report for a detailed analysis of CRON.CA support and resistance levels.
The Revenue of CRONOS GROUP INC (CRON.CA) is expected to grow by 38.35% in the next year. Check the estimates tab for more information on the CRON.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CRON.CA does not pay a dividend.
CRONOS GROUP INC (CRON.CA) will report earnings on 2025-03-04, after the market close.
CRONOS GROUP INC (CRON.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
ChartMill assigns a technical rating of 1 / 10 to CRON.CA. When comparing the yearly performance of all stocks, CRON.CA is a bad performer in the overall market: 75.08% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to CRON.CA. No worries on liquidiy or solvency for CRON.CA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months CRON.CA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 77.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -4.01% | ||
ROE | -4.39% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 75% to CRON.CA. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 7.27% and a revenue growth 38.35% for CRON.CA